(MENAFN- EIN Presswire)
Sarcopenia Treatment Market
Major factors that are expected to boost the growth of the sarcopenia treatment market is the rise in incidence of the elderly population.
In 2020, Asia-Pacific dominated the market for sarcopenia treatment and held the largest revenue share in 2020, highest growth rate majorly due to changing increasing healthcare facilities.” - Allied Market ResearchPORTLAND, OREGON, UNITED STATES, February 14, 2024 /EINPresswire / -- According to the report published by Allied Market Research, the global sarcopenia treatment market generated $2.57 billion in 2020, and is anticipated to reach $4.70 billion by 2030, witnessing a CAGR of 6.1% from 2021 to 2030. In-depth information about opportunities, key drivers, restraints, and their impact analysis on the market is offered in the report.
Sarcopenia, characterized by the loss of skeletal muscle mass and function, poses a significant health concern, particularly among the elderly population. With the global demographic shift towards an aging population, the prevalence of sarcopenia is on the rise, driving the demand for effective treatment options. In response to this growing need, the sarcopenia treatment market has witnessed notable advancements and innovations aimed at addressing the challenges associated with this condition.
Request Sample Copy of Report –
Key Drivers and Trends:
Several factors contribute to the growth of the sarcopenia treatment market. These include:
Aging Population: The aging population worldwide is a primary driver of the sarcopenia treatment market. As individuals age, they are more susceptible to muscle loss, thereby increasing the demand for effective treatment options.
Technological Advancements: Advances in medical technology have led to the development of innovative diagnostic tools and therapeutic approaches for sarcopenia. These advancements enable early detection and personalized treatment strategies, thereby driving market growth.
Rising Healthcare Expenditure: Increasing healthcare expenditure, particularly in developed economies, has facilitated greater investment in research and development activities focused on sarcopenia treatment.
Collaborative Efforts: Collaboration between pharmaceutical companies, research institutions, and healthcare providers has accelerated the pace of drug discovery and development in the sarcopenia treatment market.
Have Any Query? Ask Our Expert @:
The global sarcopenia treatment market is classified on the basis of treatment, route of administration, distribution channel, and region. By treatment, the market is divided into vitamin B12 supplement, Vitamin D & Calcium supplement, protein supplements and others. By route of administration, the market is segmented into oral, parenteral, and enteral. The oral segment is further segmented into hospital pharmacies, drug stores & retail pharmacies and online pharmacies. The parenteral segment is further segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The enteral segment is further segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. By distribution channel, it is categorized hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. By region, the market is analyzed across, North America, Europe, Asia-Pacific and LAMEA.
Key Findings Of The Study
By treatment, the protein supplement segment witnessed the highest growth with a CAGR of 5.9% in the global sarcopenia treatment market in 2020.
By route of administration, the oral segment held the largest market share in 2020 and is expected to remain dominant throughout the forecast period.
By distribution channel, the hospital pharmacies segment exhibits the fastest growth and is expected to grow at a CAGR of 5.5% from 2021 to 2030.
By region, Asia-Pacific is expected to experience a growth at the highest rate, registering a CAGR of 7.5% during the forecast period.
Key Benefits For Stakeholders
The study provides an in-depth analysis of the sarcopenia treatment market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers sarcopenia treatment market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global sarcopenia treatment market growth.
Other Trending Reports in Life Science Domain-
Influenza Treatment Market
Pigmentation Disorder Treatment Market
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
MENAFN14022024003118003196ID1107849812
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.